FDA Adverse Event Injury Summary report: N

XEN 45 GTS

MDR report key: 8288678 · Received January 30, 2019

Report

Report Number
3011299751-2019-00015
Event Type
Injury
Date Received
January 30, 2019
Date of Event
August 23, 2018
Report Date
January 30, 2019
Manufacturer
ALLERGAN (IRVINE)
Product Code
KYF
PMA / PMN Number
K161457
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

OLGUN, ALI, ET AL. ¿ENDOPHTHALMITIS AFTER XEN GEL STENT IMPLANTATION.¿ JOURNAL OF GLAUCOMA, VOL. 27, NO. 12, DECEMBER 2018, P. 191-194. (B)(4). THE REPORTED EVENTS OF ENDOPHTHALMITIS, VISION LOSS, EROSION, OCULAR PAIN, HYPOPYON, INFLAMMATION/IRRITATION, AND VISION ABNORMALITIES ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. MULTIPLE REQUESTS FOR FURTHER INFORMATION HAVE BEEN MADE. ALLERGAN HAS RECEIVED NO RESPONSE FROM THE AUTHORS. DEVICE LABELING: THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 1

REPORTED EVENTS OF VISUAL ACUITY WAS HAND MOTION, PAIN, REDNESS, EYELIDS AND CONJUNCTIVA WERE HYPEREMIC AND EDEMATOUS WERE DUE TO ENDOPHTHALMITIS, ANTERIOR CHAMBER HAD +3 CELLS AND EXHIBITED HYPOPYON, AND B-SCAN ULTRASONOGRAPHY REVEALED VITREOUS CONDENSATION AND HIGH INTRAOCULAR PRESSURE IN THE RIGHT EYE WERE NOTED IN THE ARTICLE "ENDOPHTHALMITIS AFTER XEN GEL STENT IMPLANTATION." PUBLISHED IN THE JOURNAL OF GLAUCOMA, VOL. 27, NO. 12, 2018, P.191-194. THIS MEDWATCH IS FOR THE 2ND CASE. SEE MFR # 3011299751-2019-00014 FOR THE 1ST CASE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
81849 XEN 45 GTS IMPLANT, EYE VALVE KYF ALLERGAN (IRVINE) NI

Patients

Seq Age Sex Outcome Treatment
1 80 YR Required Intervention